Apic Bio
Pioneering gene therapies for rare neurological and liver diseases, targeting Alpha-1 Antitrypsin Deficiency, genetic ALS, and other CNS conditions.
est. 2017
Coave Therapeutics is the older company (2017 vs 2014).
Side-by-Side Comparison
| Metric | Apic Bio | Coave Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2017 | 2014 older |
| Headquarters | ||
| Headquarters | Not tracked yet | Paris, France |
| Employees | ||
| Employees | Not tracked yet | 36 |
| Industry | ||
| Industry | Biotechnology, Health Care, Life Sciences | Biotechnology, Life Sciences |
| Funding Stage | ||
| Funding Stage | Series A | Grant |
| Total Funding | ||
| Total Funding | $53.32M | $79.10M |
| Funding Rounds | ||
| Funding Rounds | 3 | 7 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Gene Therapy, Rare Diseases, Neurological Disorders, Liver Diseases, Alpha-1 Antitrypsin Deficiency, ALS, Central Nervous System Disorders, Treatment Options, Pioneering Therapies, Medical Innovation | Gene Therapy, Ophthalmic Disorders, CNS Disorders, Rare Diseases, Clinical Stage Company, AAV-Ligand Conjugates Technology, ALIGATER Platform, Gene Transduction, Tissue Distribution, Unmet Medical Needs |
| Website | ||
| Website | apic-bio.com | coavetx.com |
About Apic Bio
Apic Bio is a biotechnology startup founded in 2017 with a focus on pioneering gene therapies for rare neurological and liver diseases. The company's mission is to address underserved medical conditions, including Alpha-1 Antitrypsin Deficiency (Alpha-1), genetic Amyotrophic Lateral Sclerosis (ALS),...
About Coave Therapeutics
Coave Therapeutics, a clinical stage biotechnology company, is dedicated to developing life-changing gene therapies for rare ocular and central nervous system (CNS) diseases. The company leverages its innovative AAV-Ligand Conjugates platform (ALIGATER) to enable targeted delivery and enhanced gene...
We will tell you when either one moves
BounceWatch watches Apic Bio and Coave Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Apic Bio and Coave Therapeutics — by email.
Frequently Asked Questions
Compare Apic Bio with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Apic Bio on 12 Sep 2024, and Coave Therapeutics on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.